Written answers
Wednesday, 13 January 2021
Department of Health
Cancer Services
Rose Conway-Walsh (Mayo, Sinn Fein)
Link to this: Individually | In context | Oireachtas source
887. To ask the Minister for Health if there have been supply disruptions for medication for chemotherapy at Tullamore hospital (details supplied); if there is a risk of supply-related issues in the coming months; and if he will make a statement on the matter. [45176/20]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
The HSE's National Cancer Control Programme (NCCP) advise that there have been no disruption to the supply of Systemic Anti-Cancer Therapy (SACT) to the Midlands Regional Hospital Tullamore. There was a potential delay to delivery on 22 December but this did not transpire.
In relation to the supply of parenteral SACT, the Department of Health, the HSE and the Health Products Regulatory Authority, together with the makers of parenteral SACT, wholesalers and pharmacists, are continually working to review the supply of parenteral SACT to Ireland with a view to anticipating, and responding to in so far as is possible, any potential vulnerabilities in supply.
No comments